BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsApr 28 07:31 ET

BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsApr 9 07:31 ET

TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 31 07:31 ET

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Adaptive Biotechnologies (ADPT) and Alnylam Pharma (ALNY)

TipRanksMar 31 06:56 ET

Goldman Sachs Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsMar 24 07:31 ET

Adaptive Biotechnologies Analyst Ratings

BenzingaMar 21 10:01 ET

Goldman Sachs Upgrades Adaptive Biotechnologies(ADPT.US) to Buy Rating, Raises Target Price to $9

Moomoo NewsMar 21 07:33 ET

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

MT NewswiresMar 21 07:16 ET

BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 18 07:32 ET

Adaptive Biotechnologies (ADPT) Gets a Buy From BTIG

TipRanksMar 18 06:03 ET

Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)

TipRanksFeb 20 06:31 ET

Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11

Moomoo NewsFeb 20 06:31 ET

BTIG Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10

Moomoo NewsFeb 14 07:32 ET

Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank

Dow JonesFeb 13 14:16 ET

Adaptive Biotechnologies Analyst Ratings

BenzingaFeb 13 14:06 ET

Scotiabank Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsFeb 13 07:31 ET

Stable Performance and Strategic Guidance Support Hold Rating for Adaptive Biotechnologies

TipRanksFeb 13 06:39 ET

TD Cowen Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10

Moomoo NewsFeb 12 07:32 ET

Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT) and Springworks Therapeutics (SWTX)

TipRanksFeb 11 23:25 ET

J.P. Morgan Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $8

Moomoo NewsFeb 10 18:31 ET